313 related articles for article (PubMed ID: 31239498)
1. Delivery of Rapamycin Using In Situ Forming Implants Promotes Immunoregulation and Vascularized Composite Allograft Survival.
Sutter D; Dzhonova DV; Prost JC; Bovet C; Banz Y; Rahnfeld L; Leroux JC; Rieben R; Vögelin E; Plock JA; Luciani P; Taddeo A; Schnider JT
Sci Rep; 2019 Jun; 9(1):9269. PubMed ID: 31239498
[TBL] [Abstract][Full Text] [Related]
2. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.
Plock JA; Schnider JT; Zhang W; Schweizer R; Tsuji W; Kostereva N; Fanzio PM; Ravuri S; Solari MG; Cheng HY; Rubin PJ; Marra KG; Gorantla VS
Transplantation; 2015 Sep; 99(9):1765-73. PubMed ID: 26102613
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the Crucial Roles of FoxP3+ Regulatory T Cells in Vascularized Composite Allograft Tolerance Induction and Maintenance.
Anggelia MR; Cheng HY; Chuang WY; Hsieh YH; Wang AYL; Lin CH; Wei FC; Brandacher G; Lin CH
Transplantation; 2021 Jun; 105(6):1238-1249. PubMed ID: 33141809
[TBL] [Abstract][Full Text] [Related]
4. The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation.
Plock JA; Schnider JT; Schweizer R; Zhang W; Tsuji W; Waldner M; Solari MG; Marra KG; Rubin JP; Gorantla VS
Transplantation; 2017 Jan; 101(1):e1-e11. PubMed ID: 27893612
[TBL] [Abstract][Full Text] [Related]
5. Local Injections of Tacrolimus-loaded Hydrogel Reduce Systemic Immunosuppression-related Toxicity in Vascularized Composite Allotransplantation.
Dzhonova DV; Olariu R; Leckenby J; Banz Y; Prost JC; Dhayani A; Vemula PK; Voegelin E; Taddeo A; Rieben R
Transplantation; 2018 Oct; 102(10):1684-1694. PubMed ID: 29794937
[TBL] [Abstract][Full Text] [Related]
6. The Effect of MHC Antigen Matching Between Donors and Recipients on Skin Tolerance of Vascularized Composite Allografts.
Shanmugarajah K; Powell H; Leonard DA; Mallard C; Albritton A; Harrington E; Randolph MA; Farkash E; Sachs DH; Kurtz JM; Cetrulo CL
Am J Transplant; 2017 Jul; 17(7):1729-1741. PubMed ID: 28035752
[TBL] [Abstract][Full Text] [Related]
7. Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation.
Olariu R; Denoyelle J; Leclère FM; Dzhonova DV; Gajanayake T; Banz Y; Hayoz M; Constantinescu M; Rieben R; Vögelin E; Taddeo A
J Surg Res; 2017 Oct; 218():49-57. PubMed ID: 28985877
[TBL] [Abstract][Full Text] [Related]
8. Vascularized composite allograft transplant survival in miniature swine: is MHC tolerance sufficient for acceptance of epidermis?
Cetrulo CL; Torabi R; Scalea JR; Shimizu A; Leto Barone AA; Gillon BC; Tasaki M; Leonard DA; Cormack TA; Villani V; Randolph MA; Sachs DH; Yamada K
Transplantation; 2013 Dec; 96(11):966-74. PubMed ID: 24056624
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous transplantation of hematopoietic stem cells and a vascularized composite allograft leads to tolerance.
Mathes DW; Chang J; Hwang B; Graves SS; Storer BE; Butts-Miwongtum T; Sale GE; Storb R
Transplantation; 2014 Jul; 98(2):131-8. PubMed ID: 24918616
[TBL] [Abstract][Full Text] [Related]
10. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
[TBL] [Abstract][Full Text] [Related]
11. Vascularized composite allograft tolerance across MHC barriers in a large animal model.
Leonard DA; Kurtz JM; Mallard C; Albritton A; Duran-Struuck R; Farkash EA; Crepeau R; Matar A; Horner BM; Randolph MA; Sachs DH; Huang CA; Cetrulo CL
Am J Transplant; 2014 Feb; 14(2):343-55. PubMed ID: 24405666
[TBL] [Abstract][Full Text] [Related]
12. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
[TBL] [Abstract][Full Text] [Related]
13. Graft-implanted, enzyme responsive, tacrolimus-eluting hydrogel enables long-term survival of orthotopic porcine limb vascularized composite allografts: A proof of concept study.
Fries CA; Lawson SD; Wang LC; Slaughter KV; Vemula PK; Dhayani A; Joshi N; Karp JM; Rickard RF; Gorantla VS; Davis MR
PLoS One; 2019; 14(1):e0210914. PubMed ID: 30677062
[TBL] [Abstract][Full Text] [Related]
14. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.
Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G
Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238
[TBL] [Abstract][Full Text] [Related]
15. A local drug delivery system prolongs graft survival by dampening T cell infiltration and neutrophil extracellular trap formation in vascularized composite allografts.
Arenas Hoyos I; Helmer A; Yerly A; Lese I; Hirsiger S; Zhang L; Casoni D; Garcia L; Petrucci M; Hammer SE; Duckova T; Banz Y; Montani M; Constantinescu M; Vögelin E; Bordon G; Aleandri S; Prost JC; Taddeo A; Luciani P; Rieben R; Sorvillo N; Olariu R
Front Immunol; 2024; 15():1387945. PubMed ID: 38887281
[TBL] [Abstract][Full Text] [Related]
16. Combination of a CD26 Inhibitor, G-CSF, and Short-term Immunosuppressants Modulates Allotransplant Survival and Immunoregulation in a Rodent Hindlimb Allotransplant Model.
Chen CC; Chen RF; Wang YC; Li YT; Chuang JH; Kuo YR
Transplantation; 2021 Jun; 105(6):1250-1260. PubMed ID: 33093401
[TBL] [Abstract][Full Text] [Related]
17. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
Zhu P; Bailey SR; Lei B; Paulos CM; Atkinson C; Tomlinson S
Transplantation; 2017 Apr; 101(4):e75-e85. PubMed ID: 28045880
[TBL] [Abstract][Full Text] [Related]
18. Treg-inducing microparticles promote donor-specific tolerance in experimental vascularized composite allotransplantation.
Fisher JD; Balmert SC; Zhang W; Schweizer R; Schnider JT; Komatsu C; Dong L; Erbas VE; Unadkat JV; Aral AM; Acharya AP; Kulahci Y; Turnquist HR; Thomson AW; Solari MG; Gorantla VS; Little SR
Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25784-25789. PubMed ID: 31792185
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous resolution of acute rejection and tolerance induction with IL-2 fusion protein in vascularized composite allotransplantation.
Jindal R; Unadkat J; Zhang W; Zhang D; Ng TW; Wang Y; Jiang J; Lakkis F; Rubin P; Lee WP; Gorantla VS; Zheng XX
Am J Transplant; 2015 May; 15(5):1231-40. PubMed ID: 25676865
[TBL] [Abstract][Full Text] [Related]
20. Topical Tacrolimus and Mycophenolic Acid Therapy Synergizes with Low Dose Systemic Immunosuppression to Sustain Vascularized Composite Allograft Survival.
Feturi FG; Zhang W; Erbas VE; Dong L; Sahin H; Zhang Z; Oksuz S; Spiess AM; Solari MG; Venkataramanan R; Gorantla VS
J Pharm Sci; 2024 Jun; 113(6):1607-1615. PubMed ID: 38309457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
